Company: BDRX
Filing Date: 2025-01-28
Form Type: 424B3
Source: 0001214659-25-001409
Chunk: 236

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-28
Form: 424B3
Chunk 236
---
 a normal commercial basis and in accordance with the related party rules set out in
the AIM Rules.

The Relationship Agreement
provides that any respective dispute between the Company and the CMS Parties and/or any of their respective associates relating to any
existing or proposed transaction, arrangement or agreement between each of CMS Parties (or any of their associates) and the Company shall
be resolved by a decision of the majority of independent directors.

| 117 |

The obligations of the parties
under the Relationship Agreement shall automatically terminate upon:

| • | the CMS Parties (or any of their associates) ceasing to beneficially hold 10%, in aggregate, of our issued Ordinary Shares; or |

| • | the Ordinary Shares ceasing to be admitted to AIM. |

In connection with the closing
of a private placement on February 15, 2023, the CMS Parties beneficially owned less than 10%, in aggregate, of our issued Ordinary Shares,
and accordingly, the Relationship Agreement terminated in accordance with its terms.

Deed of Indemnity

We have entered into a Deed
of Indemnity for the benefit of our Board of Directors and Company Secretary. For more information, see “Management—Compensation of Non-Executive Directors—Deed of Indemnity.”

Agreements with Directors and Senior Management

We have previously entered
into certain agreements with directors and our senior management related to their service on our Board of Directors or employment with
the Company. For more information, see “Management.”

| 118 |

<div align='center'>PRINCIPAL SHAREHOLDERS</div>

The following table sets forth information, to
our knowledge, as of December 31, 2024, regarding the beneficial ownership of Ordinary Shares, including:

| · | each person that is known by us to be a beneficial owner of 5% or more of Ordinary Shares (based on information 
 in our share register and information provided by such persons);                                                |

| · | each member of our Board of Directors; |

| · | each member of our senior management; and |

| · | all members of our Board of Directors and our senior management, taken as a group. |

Beneficial ownership of shares
is determined under rules of the SEC and generally includes any shares over which a person exercises sole or shared voting or investment
power. Except as noted by footnote, and subject to community property laws where applicable, we believe, based upon the information provided
to us, that the persons and entities named in